SARS-CoV-2 NSP12 (RdRP) anticorps (C-Term)
Aperçu rapide pour SARS-CoV-2 NSP12 (RdRP) anticorps (C-Term) (ABIN7273004)
Antigène
Voir toutes SARS-CoV-2 NSP12 (RdRP) (SARS-CoV-2 RdRP) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée (Details)
- Reacts with SARS-CoV-2 protein
-
Purification
- Epitope affinity purified
-
Immunogène
- Affinity purified recombinant fusion protein using the C-terminal of Nsp12 (residues 820 to stop) and produced in E. coli.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:2,000
-
Commentaires
-
In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 3 mg/mL
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at -20 °C for long-term storage. Store at 2-8 °C for up to one month.
-
-
- SARS-CoV-2 NSP12 (RdRP) (SARS-CoV-2 RdRP) (SARS-CoV-2 RNA-dependent RNA Polymerase (NSP12) (SARS-CoV-2 RdRP))
-
Autre désignation
- NSP12 (SARS-CoV-2)
-
Classe de substances
- Viral Protein
Antigène
-